Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 21, 2011
Subject: Regulation FD Disclosure regarding a government inquiry.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a disclosure of a legal inquiry rather than a financial report.
Material Changes
No material financial changes are reported. The material event disclosed is the receipt of a request for documents, potentially including an administrative subpoena, from the Office of Inspector General for the U.S. Department of Health and Human Services.
Outlook, Risks, and Management Commentary
- Inquiry Details: The request is connected to an inquiry by the United States Attorney's office for the Eastern District of New York regarding payments for infusion drugs covered by the New York Medicaid composite payment system for dialysis.
- Nature of Inquiry: Management believes the inquiry is civil in nature. The specific time period covered is unknown.
- Industry Context: The Company understands that other dialysis providers in New York serving Medicaid patients may also be receiving similar requests.
- Company Response: DaVita intends to cooperate with the government to provide responsive documents.
- Legal Status: To the Company's knowledge, no proceedings have been initiated against it at this time.
- Potential Risks: Negative findings could result in substantial financial penalties, exclusion from future participation in Medicare and Medicaid programs, and criminal penalties.
Investor Verification Checklist
- Verify if any formal proceedings or penalties have been initiated against DaVita since the filing date.
- Monitor for updates regarding the scope of the New York Medicaid infusion drug inquiry.
- Assess the potential financial impact of exclusion from Medicare/Medicaid programs on future revenue streams.
- Check for similar inquiries or penalties affecting peer dialysis providers in New York.